Completed enrollment in 4D-150 4FRONT-1 wet AMD Phase 3 trial within approximately 11 months, ahead of initial projections and reflecting strong interest from investigators and patients; topline data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results